Global Neurosyphilis Market Size, Status and Forecast 2020-2026

世界の神経梅毒市場2026:インサイト・予測

◆タイトル:Global Neurosyphilis Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV03962
◆調査・発行会社:QYResearch
◆発行日:2020年11月
◆ページ数:97
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥421,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥631,800見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートは神経梅毒の世界市場について調査・分析した資料です。種類別(無症候性神経梅毒、髄膜神経梅毒、髄膜血管神経梅毒、進行麻痺、脊髄癆)の市場規模、用途別(病院および診療所、医学研究センター、学術研究所)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別神経梅毒の競争状況、市場シェア
・世界の神経梅毒市場:種類別市場規模 2015年-2020年(無症候性神経梅毒、髄膜神経梅毒、髄膜血管神経梅毒、進行麻痺、脊髄癆)
・世界の神経梅毒市場:種類別市場規模予測 2021年-2026年(無症候性神経梅毒、髄膜神経梅毒、髄膜血管神経梅毒、進行麻痺、脊髄癆)
・世界の神経梅毒市場:用途別市場規模 2015年-2020年(病院および診療所、医学研究センター、学術研究所)
・世界の神経梅毒市場:用途別市場規模予測 2021年-2026年(病院および診療所、医学研究センター、学術研究所)
・北米の神経梅毒市場分析:米国、カナダ
・ヨーロッパの神経梅毒市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの神経梅毒市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の神経梅毒市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの神経梅毒市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Abbott、Bayer、Eli Lilly and Company、GlaxoSmithKline、Novartis、Pfizer、Sanofi
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Neurosyphilis is an infection of the brain or spinal cord caused by the spirochete Treponema pallidum. It usually occurs in people who have had chronic, untreated syphilis, usually about 10 to 20 years after first infection and develops in about 25%–40% of those who are not treated. The United States’ Centers for Disease Control and Prevention (CDC) advises that neurosyphilis can occur at any stage of a syphilis infection.
Neurosyphilis has four different forms: asymptomatic, meningovascular, tabes dorsalis, and general paresis. In rare instances, active neurosyphilis can mimic Alzheimer’s disease. In addition to evaluation of any symptoms and signs, various blood tests can be done. Additional tests to look for problems with the nervous system may include Cerebral angiogram, Head CT scan, Lumbar puncture and MRI scan of the brain, brainstem, or spinal cord.

Market Analysis and Insights: Global Neurosyphilis Market
The global Neurosyphilis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Neurosyphilis Scope and Market Size
Neurosyphilis market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neurosyphilis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Abbott
Bayer
Eli Lilly and Company
GlaxoSmithKline
Novartis
Pfizer
Sanofi

Market segment by Type, the product can be split into
Asymptomatic Neurosyphilis
Meningeal Neurosyphilis
Meningovascular Neurosyphilis
General Paresis
Tabes Dorsalis
Market segment by Application, split into
Hospital And Clinics
Medical Research Centers
Academic Institutes

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Neurosyphilis Revenue
1.4 Market by Type
1.4.1 Global Neurosyphilis Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Asymptomatic Neurosyphilis
1.4.3 Meningeal Neurosyphilis
1.4.4 Meningovascular Neurosyphilis
1.4.5 General Paresis
1.4.6 Tabes Dorsalis
1.5 Market by Application
1.5.1 Global Neurosyphilis Market Share by Application: 2020 VS 2026
1.5.2 Hospital And Clinics
1.5.3 Medical Research Centers
1.5.4 Academic Institutes
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Neurosyphilis Market Perspective (2015-2026)
2.2 Global Neurosyphilis Growth Trends by Regions
2.2.1 Neurosyphilis Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Neurosyphilis Historic Market Share by Regions (2015-2020)
2.2.3 Neurosyphilis Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Neurosyphilis Market Growth Strategy
2.3.6 Primary Interviews with Key Neurosyphilis Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Neurosyphilis Players by Market Size
3.1.1 Global Top Neurosyphilis Players by Revenue (2015-2020)
3.1.2 Global Neurosyphilis Revenue Market Share by Players (2015-2020)
3.1.3 Global Neurosyphilis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Neurosyphilis Market Concentration Ratio
3.2.1 Global Neurosyphilis Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Neurosyphilis Revenue in 2019
3.3 Neurosyphilis Key Players Head office and Area Served
3.4 Key Players Neurosyphilis Product Solution and Service
3.5 Date of Enter into Neurosyphilis Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Neurosyphilis Historic Market Size by Type (2015-2020)
4.2 Global Neurosyphilis Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Neurosyphilis Market Size by Application (2015-2020)
5.2 Global Neurosyphilis Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Neurosyphilis Market Size (2015-2020)
6.2 Neurosyphilis Key Players in North America (2019-2020)
6.3 North America Neurosyphilis Market Size by Type (2015-2020)
6.4 North America Neurosyphilis Market Size by Application (2015-2020)

7 Europe
7.1 Europe Neurosyphilis Market Size (2015-2020)
7.2 Neurosyphilis Key Players in Europe (2019-2020)
7.3 Europe Neurosyphilis Market Size by Type (2015-2020)
7.4 Europe Neurosyphilis Market Size by Application (2015-2020)

8 China
8.1 China Neurosyphilis Market Size (2015-2020)
8.2 Neurosyphilis Key Players in China (2019-2020)
8.3 China Neurosyphilis Market Size by Type (2015-2020)
8.4 China Neurosyphilis Market Size by Application (2015-2020)

9 Japan
9.1 Japan Neurosyphilis Market Size (2015-2020)
9.2 Neurosyphilis Key Players in Japan (2019-2020)
9.3 Japan Neurosyphilis Market Size by Type (2015-2020)
9.4 Japan Neurosyphilis Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Neurosyphilis Market Size (2015-2020)
10.2 Neurosyphilis Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Neurosyphilis Market Size by Type (2015-2020)
10.4 Southeast Asia Neurosyphilis Market Size by Application (2015-2020)

11 India
11.1 India Neurosyphilis Market Size (2015-2020)
11.2 Neurosyphilis Key Players in India (2019-2020)
11.3 India Neurosyphilis Market Size by Type (2015-2020)
11.4 India Neurosyphilis Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Neurosyphilis Market Size (2015-2020)
12.2 Neurosyphilis Key Players in Central & South America (2019-2020)
12.3 Central & South America Neurosyphilis Market Size by Type (2015-2020)
12.4 Central & South America Neurosyphilis Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Neurosyphilis Introduction
13.1.4 Abbott Revenue in Neurosyphilis Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Neurosyphilis Introduction
13.2.4 Bayer Revenue in Neurosyphilis Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Eli Lilly and Company
13.3.1 Eli Lilly and Company Company Details
13.3.2 Eli Lilly and Company Business Overview
13.3.3 Eli Lilly and Company Neurosyphilis Introduction
13.3.4 Eli Lilly and Company Revenue in Neurosyphilis Business (2015-2020)
13.3.5 Eli Lilly and Company Recent Development
13.4 GlaxoSmithKline
13.4.1 GlaxoSmithKline Company Details
13.4.2 GlaxoSmithKline Business Overview
13.4.3 GlaxoSmithKline Neurosyphilis Introduction
13.4.4 GlaxoSmithKline Revenue in Neurosyphilis Business (2015-2020)
13.4.5 GlaxoSmithKline Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Neurosyphilis Introduction
13.5.4 Novartis Revenue in Neurosyphilis Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Pfizer
13.6.1 Pfizer Company Details
13.6.2 Pfizer Business Overview
13.6.3 Pfizer Neurosyphilis Introduction
13.6.4 Pfizer Revenue in Neurosyphilis Business (2015-2020)
13.6.5 Pfizer Recent Development
13.7 Sanofi
13.7.1 Sanofi Company Details
13.7.2 Sanofi Business Overview
13.7.3 Sanofi Neurosyphilis Introduction
13.7.4 Sanofi Revenue in Neurosyphilis Business (2015-2020)
13.7.5 Sanofi Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Neurosyphilis Key Market Segments
Table 2. Key Players Covered: Ranking by Neurosyphilis Revenue
Table 3. Ranking of Global Top Neurosyphilis Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Neurosyphilis Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Asymptomatic Neurosyphilis
Table 6. Key Players of Meningeal Neurosyphilis
Table 7. Key Players of Meningovascular Neurosyphilis
Table 8. Key Players of General Paresis
Table 9. Key Players of Tabes Dorsalis
Table 10. Global Neurosyphilis Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Neurosyphilis Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Neurosyphilis Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Neurosyphilis Market Share by Regions (2015-2020)
Table 14. Global Neurosyphilis Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Neurosyphilis Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Neurosyphilis Market Growth Strategy
Table 20. Main Points Interviewed from Key Neurosyphilis Players
Table 21. Global Neurosyphilis Revenue by Players (2015-2020) (Million US$)
Table 22. Global Neurosyphilis Market Share by Players (2015-2020)
Table 23. Global Top Neurosyphilis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurosyphilis as of 2019)
Table 24. Global Neurosyphilis by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Neurosyphilis Product Solution and Service
Table 27. Date of Enter into Neurosyphilis Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Neurosyphilis Market Size by Type (2015-2020) (Million US$)
Table 30. Global Neurosyphilis Market Size Share by Type (2015-2020)
Table 31. Global Neurosyphilis Revenue Market Share by Type (2021-2026)
Table 32. Global Neurosyphilis Market Size Share by Application (2015-2020)
Table 33. Global Neurosyphilis Market Size by Application (2015-2020) (Million US$)
Table 34. Global Neurosyphilis Market Size Share by Application (2021-2026)
Table 35. North America Key Players Neurosyphilis Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Neurosyphilis Market Share (2019-2020)
Table 37. North America Neurosyphilis Market Size by Type (2015-2020) (Million US$)
Table 38. North America Neurosyphilis Market Share by Type (2015-2020)
Table 39. North America Neurosyphilis Market Size by Application (2015-2020) (Million US$)
Table 40. North America Neurosyphilis Market Share by Application (2015-2020)
Table 41. Europe Key Players Neurosyphilis Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Neurosyphilis Market Share (2019-2020)
Table 43. Europe Neurosyphilis Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Neurosyphilis Market Share by Type (2015-2020)
Table 45. Europe Neurosyphilis Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Neurosyphilis Market Share by Application (2015-2020)
Table 47. China Key Players Neurosyphilis Revenue (2019-2020) (Million US$)
Table 48. China Key Players Neurosyphilis Market Share (2019-2020)
Table 49. China Neurosyphilis Market Size by Type (2015-2020) (Million US$)
Table 50. China Neurosyphilis Market Share by Type (2015-2020)
Table 51. China Neurosyphilis Market Size by Application (2015-2020) (Million US$)
Table 52. China Neurosyphilis Market Share by Application (2015-2020)
Table 53. Japan Key Players Neurosyphilis Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Neurosyphilis Market Share (2019-2020)
Table 55. Japan Neurosyphilis Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Neurosyphilis Market Share by Type (2015-2020)
Table 57. Japan Neurosyphilis Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Neurosyphilis Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Neurosyphilis Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Neurosyphilis Market Share (2019-2020)
Table 61. Southeast Asia Neurosyphilis Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Neurosyphilis Market Share by Type (2015-2020)
Table 63. Southeast Asia Neurosyphilis Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Neurosyphilis Market Share by Application (2015-2020)
Table 65. India Key Players Neurosyphilis Revenue (2019-2020) (Million US$)
Table 66. India Key Players Neurosyphilis Market Share (2019-2020)
Table 67. India Neurosyphilis Market Size by Type (2015-2020) (Million US$)
Table 68. India Neurosyphilis Market Share by Type (2015-2020)
Table 69. India Neurosyphilis Market Size by Application (2015-2020) (Million US$)
Table 70. India Neurosyphilis Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Neurosyphilis Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Neurosyphilis Market Share (2019-2020)
Table 73. Central & South America Neurosyphilis Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Neurosyphilis Market Share by Type (2015-2020)
Table 75. Central & South America Neurosyphilis Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Neurosyphilis Market Share by Application (2015-2020)
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Product
Table 80. Abbott Revenue in Neurosyphilis Business (2015-2020) (Million US$)
Table 81. Abbott Recent Development
Table 82. Bayer Company Details
Table 83. Bayer Business Overview
Table 84. Bayer Product
Table 85. Bayer Revenue in Neurosyphilis Business (2015-2020) (Million US$)
Table 86. Bayer Recent Development
Table 87. Eli Lilly and Company Company Details
Table 88. Eli Lilly and Company Business Overview
Table 89. Eli Lilly and Company Product
Table 90. Eli Lilly and Company Revenue in Neurosyphilis Business (2015-2020) (Million US$)
Table 91. Eli Lilly and Company Recent Development
Table 92. GlaxoSmithKline Company Details
Table 93. GlaxoSmithKline Business Overview
Table 94. GlaxoSmithKline Product
Table 95. GlaxoSmithKline Revenue in Neurosyphilis Business (2015-2020) (Million US$)
Table 96. GlaxoSmithKline Recent Development
Table 97. Novartis Company Details
Table 98. Novartis Business Overview
Table 99. Novartis Product
Table 100. Novartis Revenue in Neurosyphilis Business (2015-2020) (Million US$)
Table 101. Novartis Recent Development
Table 102. Pfizer Company Details
Table 103. Pfizer Business Overview
Table 104. Pfizer Product
Table 105. Pfizer Revenue in Neurosyphilis Business (2015-2020) (Million US$)
Table 106. Pfizer Recent Development
Table 107. Sanofi Company Details
Table 108. Sanofi Business Overview
Table 109. Sanofi Product
Table 110. Sanofi Revenue in Neurosyphilis Business (2015-2020) (Million US$)
Table 111. Sanofi Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurosyphilis Market Share by Type: 2020 VS 2026
Figure 2. Asymptomatic Neurosyphilis Features
Figure 3. Meningeal Neurosyphilis Features
Figure 4. Meningovascular Neurosyphilis Features
Figure 5. General Paresis Features
Figure 6. Tabes Dorsalis Features
Figure 7. Global Neurosyphilis Market Share by Application: 2020 VS 2026
Figure 8. Hospital And Clinics Case Studies
Figure 9. Medical Research Centers Case Studies
Figure 10. Academic Institutes Case Studies
Figure 11. Neurosyphilis Report Years Considered
Figure 12. Global Neurosyphilis Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Neurosyphilis Market Share by Regions: 2020 VS 2026
Figure 14. Global Neurosyphilis Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Neurosyphilis Market Share by Players in 2019
Figure 17. Global Top Neurosyphilis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurosyphilis as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Neurosyphilis Revenue in 2019
Figure 19. North America Neurosyphilis Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Neurosyphilis Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Neurosyphilis Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Neurosyphilis Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Neurosyphilis Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Neurosyphilis Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Neurosyphilis Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の神経梅毒市場2026:インサイト・予測] (Global Neurosyphilis Market Size, Status and Forecast 2020-2026 / QYR20NV03962)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆